MicroIslet to Present at Rodman & Renshaw Global Healthcare ConferenceThursday

http://biz.yahoo.com/prnews/060511/lath072.html?.v=56
May 11, 12:03 pm ET

approach to treating insulin-dependent diabetes through minimally invasive transplantation of microencapsulated, insulin-producing porcine islets.

Boston anticipates the most comprehensive transplantation conference July 2006

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-20-2006/0004344154&EDATE=
MOUNT LAUREL, N.J., April 20 /PRNewswire/ -- The World TransplantCongress 2006 (WTC) is the first international joint transplant conference,focusing on the most timely and important topics in the field oftransplantation medicine. Over the past six years, physicians, surgeons,scientists, nurses, organ procurement personnel and pharmacists in thefield of basic and clinical transplantation have gathered in masses toattend the American Transplant Congress (ATC) in various cities across theUnited States. This year, the ATC and The International Congress of TheTransplantation Society are replaced by the WTC 2006.

Visit http://www.wtc2006.org/ for details, meeting schedule, keyspeakers, and more. Media interviews are welcomed and can be arranged. Ifinterested, contact Steven Schiff 610-449-8056; steve@schiffmarketing.com.

Encouraging Data From Islet Transplantation Studies In Primates, MicroIslet, Inc.

http://www.medicalnewstoday.com/medicalnews.php?newsid=41536
Article Date: 16 Apr 2006 - 0:00am (PDT)MicroIslet, Inc. (Amex: MII), a biotechnology company engaged in the research, development and commercialization of patented technologies in transplantation therapy for people with insulin-dependent diabetes, today announced encouraging data from preclinical primate studies.

The latest in DIY is just around the corner, with scientists using our own cells to build us new body parts, writes Deborah Smith.

http://www.smh.com.au/news/science/own-grown-the-way-to-go/2006/04/12/1144521401102.html
This research is expected to lead soon to the development of grow-your-own grafts for kidney patients who need the vessels for access to hemodialysis machines. At present the artificial grafts used can start to fail after 12 months, according to Kidney Health Australia.

By 2010 Cell Based Markets Are Expected to Account for $56.2 Billion Which Will Continue to Increase to $96.3 Billion by 2015

http://www.genengnews.com/news/bnitem.aspx?name=329787
BIOWIRE
Research and Markets (http://www.researchandmarkets.com/reports/c10806) has announced the addition of the Jain PharmaBiotech report: Cell Therapy - Technologies, Markets and Companies to their offering.
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Cell therapy is bound to become a part of medical practice.

4/10/2006 3:00:00 PM EST

Seven patients in the US had bladder transplants after the bladder was artificially grown in a laboratory.

http://www.irishhealth.com/?level=4&id=9280

Scientists Successfully Rebuild Bladder and Transplant it

http://www.wlns.com/Global/story.asp?S=4721751&nav=0RbQ
Dr. Anthony Atala: "Currently we're working on several other projects, including regeneration of cardiac muscle, heart, liver, pancreas, nerve, kidney, blood vessels."